Accelerated Cell Aging in Female APOE-ε4 Carriers: Implications for Hormone Therapy Use

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Jacobs, Emily G ^a,d   Kroenke, Candyce ^b   Lin, Jue ^a   Epel, Elissa S ^a   Kenna, Heather A ^c   Blackburn, Elizabeth H ^a   Rasgon, Natalie L ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; ESTROGEN; PROGESTERONE;

ADULT; AGE DISTRIBUTION; AGED; APOE EPSILON4 GENE; ARTICLE; CELL AGING; CORRELATIONAL STUDY; DEMENTIA; FEMALE; GENE; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; LEUKOCYTE STRUCTURE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; QUANTITATIVE STUDY; RISK FACTOR; SENESCENCE; TELOMERE SHORTENING;

ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CELL AGING; COGNITION DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; RISK FACTORS; TELOMERE SHORTENING;

EID: 84873911119     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054713     Document Type: Article

References (65)

1. Carrero JJ, Stenvinkel P, Fellstrom B, Qureshi AR, Lamb K, et al. (2008) Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Int Med 263: 302-312.
2. O'Donovan A, Pantell MS, Puterman E, Dhabhar FS, Blackburn E, et al. (2011) Cumulative inflammatory load is associated with short leukocyte telomere length in the health, aging and body composition study. Plos One 6: e19687.
3. Aviv A (2011) Leukocyte telomere dynamics, human aging, and life span. In: Masoro EJ, Austad SN, editors. Handbook of the Biology of Aging. Academic Press, London. 163-176.
4. Blackburn EH, (1991) Structure and function of telomeres. Nature 350: 569-573.
5. Blackburn EH, (2000) Telomere states and cell fates. Nature 408: 53-56.
6. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ, (2003) White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 23: 842-846.
7. Benetos A, Gardner JP, Zureik M, Labat C, Xiaobin L, et al. (2004) Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 43: 182-185.
8. von Zglinicki T, Serra V, Lorenz M, Saretzki G, Lenxen-Grobimlighaus R, et al. (2000) Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest 80: 1739-1747.
9. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, et al. (2003) Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 24: 77-84.
10. Lin J, Epel ES, Blackburn EH (2009) Telomeres, telomerase, stress and aging. In: Berntson GG, Cacioppo JT, editors. Handbook of Neuroscience for the Behavioral Sciences. New Jersey: John Wiley and Sons. 1280-1295.
11. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA, (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361: 393-395.
12. Honig LS, Schupf N, Lee JH, Tang MX, Mayeux R, (2006) Shorter telomeres are associated with mortality in those with APOE ε4 and dementia. Ann Neurol 60: 181-187.
13. Martin-Ruiz CM, Dickinson HO, Keys B, Rowan E, Kenny RA, et al. (2006) Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann. Neurol. 60: 174-180.
14. Epel ES, Merkin SS, Cawthon R, Blackburn EH, Adler NE, et al. (2009) The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging 1: 81-88.
15. Fitzpatrick AL, Kronmal RA, Kimura M, Gardner JP, Psaty BM, et al. (2011) Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 66: 421-429.
16. Yaffe K, Lindquist K, Kluse M, Cawthon R, Harris T, et al. (2009) Telomere length and cognitive function in community-dwelling elders: Findings from the Health ABC Study. Neurobio Aging 32: 2055-2060.
17. Valdes AM, Deary IJ, Gardner J, Kimura M, Lu X, et al. (2010) Leukocyte telomere length is associated with cognitive performance in healthy women. Neurobiol. Aging 31: 986-992.
18. Devore EE, Prescott J, De Vivo I, Grodstein F, (2011) Relative telomere length and cognitive decline in the Nurses' Health Study. Neurosci Lett 492: 15-18.
19. Mather KA, Jorm AF, Anstey KJ, Milburn PJ, Easteal S, et al. (2010) Cognitive performance and leukocyte telomere length in two narrow age-range cohorts: a population study. BMC Geriatr. 10: 62.
20. Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, et al. (2011) Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469: 102-106.
21. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, et al. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
22. Roses AD, (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol. 38: 6-14.
23. Yaffe K, Cauley J, Sands L, Browner W, (1997) Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol. 54: 1110-1114.
24. Little DM, Crooks VC, Petitti DB, Chiu V, Schellenberg GD, et al. (2009) Mortality, dementia, and apolipoprotein E genotype in elderly white women in the United States. J Am Geriatr Soc. 57: 231-6.
25. Takata Y, Kikukawa M, Hanya H, Koyama S, Shimizu S, et al. (2011) Association between ApoE phenotypes and telomere erosion in Alzheimer's disease. J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glr185.
26. Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, et al. (2002) Telomere length in the newborn. Pediatric Research 52: 377-381.
27. Aviv A, Shay J, Christensen K, Wright W, (2005) The longevity gender gap: are telomeres the explanation? Sci Aging Knowl Environ 23: pe16.
28. Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, et al. (2000) Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol. Cell. Biol. 20: 3764-3771.
29. Bayne S, Jones ME, Li H, Liu J-P, (2007) Potential roles for estrogen regulation of telomerase activity in aging. Annals NY Acad Sci 1114: 48-55.
30. Grasselli A, Nanni S, Colussi C, Aiello A, Benvenuti V, et al. (2008) Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ. Res. 103: 34-42.
31. Cha Y, Kwon SJ, Seol W, Park KS, (2008) Estrogen receptor-alpha mediates the effects of estradiol on telomerase activity in human mesenchymal stem cells. Mol. Cells 26: 454-458.
32. Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, et al. (2009) Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 114: 2236-2243.
33. Wong CM, Yung LM, Leung FP, Tsang SY, Au CL, et al. (2008) Raloxifene protects endothelial cell function against oxidative stress. Br. J. Pharmacol. 155: 326-334.
34. Song JY, Kim MJ, Jo HH, Hwang SJ, Chae B, et al. (2009) Antioxidant effect of estrogen on bovine aortic endothelial cells. J. Steroid Biochem. Mol. Biol. 117: 74-80.
35. Yokoyama Y, Takahashi Y, Morishita S, Hashimoto M, Niwa K, et al. (1998) Telomerase activity in the human endometrium throughout the menstrual cycle. Mol. Hum. Reprod. 4: 173-177.
36. Williams CD, Boggess JF, LaMarque LR, Meyer WR, Murray MJ, et al. (2001) A prospective, randomized study of endometrial telomerase during the menstrual cycle. J. Clin. Endocrinol. Metab. 86: 3912-3917.
37. Lin J, Kroenke CH, Epel E, Kenna HA, Wolkowitz OM, et al. (2011) Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline. Brain Research 1379: 224-231.
38. Lee DC, Im JA, Kim JH, Lee HR, Shim JY, (2005) Effect of long-term hormone therapy on telomere length in postmenopausal women. Yonsei Med. J. 46: 471-479.
39. Cherkas LF, Hunkin JL, Kato BS, Richards B, Gardner JP, et al. (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med. 168: 154-158.
40. Xu Q, Parks CG, DeRoo LA, Cawthon RM, Sandler DP, et al. (2009) Multivitamin use and telomere length in women. Am J Clin Nutr. 89: 1857-1863.
41. Yaffe K, (2006) Estrogens, selective estrogen receptor modulators, and dementia: What is the evidence? Annals NYAS 949: 215-222.
42. Srivastava RA, Srivastava N, Averna M, Lin RC, Korach KS, et al. (1997) Estrogen up-regulates apolipoprotein E(ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J. Biol. Chem. 272: 33360-33366.
43. Stone DJ, Rozovsky I, Moran TE, Anderson CP, Finch CE, et al. (1998) Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J. Neurosci. 18: 3180-3185.
44. Damoiseaux JS, Seeley WW, Zhou J, Shirer WR, Coppola G, et al. (2012) Gender modulates the APOE-ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J Neurosci 32: 8254-8262.
45. Raber JD, Wong D, Buttini M, Orth M, Bellosta S, et al. (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. USA 95: 10914-10919.
46. Payami HS, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, et al. (1996) Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am. J. Hum. Genet. 58: 803-811.
47. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349-1356.
48. Farlow MR, Lahiri DK, Poirer J, Davignon J, Schneider L, et al. (1998) Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neurology 50: 669-677.
49. Hixson J, Vernier D, (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548.
50. Cawthon R, (2002) Telomere measurement by quantitative PCR. Nucl. Acids Res. (2002) 30: e47.
51. Aviv A, Chen W, Gardner JP, Kimura M, Brimacombe M, et al. (2009) Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa Heart Study. Am J Epidemiol 169: 323-329.
52. Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Yahat N, et al. (1998) Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum. Genet. 102: 397-402.
53. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, et al. (1990) Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868.
54. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, et al. (2010) Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress. Plos One 6: e17837.
55. Blackburn EH, Greider CW, Szostak JW, (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12: 1133-1138.
56. Bakaysa SL, Mucci LA, Slagboom PE, Boomsma DI, McClearn GE, et al. (2007) Telomere length predicts survival independent of genetic influences. Aging Cell 6: 769-774.
57. Wikgren M, Karlsson T, Nilbrink T, Nordfjall K, Hultdin J, et al. (2012) APOE e4 is associated with longer telomeres, and longer telomeres among e4 carriers predicts worse episodic memory. Neurobiol Aging 33: 335-344.
58. Gardner JP, Li S, Srinivasan SR, Chen W, Kimura M, et al. (2005) Rise in insulin resistance is associated with escalated telomere attrition. Circulation 111: 2171-2177.
59. Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, et al. (2010) Telomere length trajectory and its determinants in persons with coronary artery disease: Longitudinal findings from the Heart and Soul Study. Plos One 5(1): e8612 doi:10.1371.
60. Imanishi T, Hano T, Nishio I, (2005) Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J. Hypertens 23: 1699-1706.
61. Sack MN, Rader DJ, Cannon RO, (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343: 269-270.
62. Wang JM, Irwin RW, Brinton RD, (2006) Activation of estrogen receptor a increases and estrogen receptor b decreases apolipoprotein E expression in the hippocampus in vitro and in vivo. PNAS 103: 16983-16988.
63. Yaffe K, Haan M, Byers A, Tangen C, Kuller L, (2000) Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54: 1949-1954.
64. Miyata M, Smith JD, (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14: 55-61.
65. Su B, Wang X, Nunomura A, Moreira PI, Lee HG, et al. (2008) Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res. 5: 525-532.